Efficacy and Safety of Itopride vs Placebo in Heartburn

Phase 3

Completed

• Conditions: Heartburn

• Registration Number: NCT00382577
• Lead Sponsor: Forest Laboratories

Brief Summary

The purpose of this study is to evaluate the effects of itopride in patients with heartburn.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-09-27
• Study First Submitted QC: 2006-09-28
• Study First Posted: 2006-09-29
• Study Start: 2006-10
• Study Completion: 2006-12
• Status Verified: 2017-02
• Last Update Submitted: 2017-02-07
• Last Update Posted: 2017-02-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• Otherwise healthy males and females aged 18-70, with at least 3 episodes of heartburn or acid regurgitation per week.

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
24-hour pH Monitoring	after 5 days of treatment

Trial Locations

Locations (1)

The Oklahoma Foundation for Digestive Research; 🇺🇸 Oklahoma City, Oklahoma, United States